LAZCLUZE
Active substance: lazertinib
TABLET, FILM COATED · LAZERTINIB 80 mg/1
United StatesActive
Marketing holder: Janssen Biotech, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- LAZERTINIB · 80 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-833e-779a-8644-70013ce088ea,01a1208f-f659-771f-b076-05f5c602ee3c;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 57894-080
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 57894-080 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 57894-080 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 57894-080 · Verified 2026-10-09 · open in source